ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Updated Efficacy Outcomes of Anti-PD-1 Antibodies plus Multikinase Inhibitors for Patients with Advanced Gastric Cancer with or without Liver Metastases in Clinical Trials.

Hiroki Yukami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.